共 50 条
- [8] Effect of guselkumab on serum biomarkers in Japanese palmoplantar pustulosis patients in a randomized phase 3 study JEADV CLINICAL PRACTICE, 2023, 2 (01): : 59 - 72
- [10] Pharmacokinetic/Pharmacodynamic Analysis of Guselkumab for Treatment of Palmoplantar Pustulosis: Clinical Implications of Guselkumab Dose, Disease Severity, and Smoking in Japanese Patients JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (02): : 182 - 189